nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—GLUL—oviduct—ovarian cancer	0.0416	0.0997	CbGeAlD
Diazoxide—ATP1A1—oviduct—ovarian cancer	0.0248	0.0594	CbGeAlD
Diazoxide—GLUL—myometrium—ovarian cancer	0.0133	0.0319	CbGeAlD
Diazoxide—GLUL—embryo—ovarian cancer	0.0128	0.0307	CbGeAlD
Diazoxide—KCNMA1—myometrium—ovarian cancer	0.0124	0.0296	CbGeAlD
Diazoxide—GLUL—epithelium—ovarian cancer	0.0105	0.025	CbGeAlD
Diazoxide—SLC12A3—female reproductive system—ovarian cancer	0.0104	0.025	CbGeAlD
Diazoxide—GLUL—uterine cervix—ovarian cancer	0.0104	0.0248	CbGeAlD
Diazoxide—GLUL—decidua—ovarian cancer	0.00987	0.0236	CbGeAlD
Diazoxide—KCNMA1—epithelium—ovarian cancer	0.0097	0.0232	CbGeAlD
Diazoxide—GLUL—endometrium—ovarian cancer	0.00937	0.0225	CbGeAlD
Diazoxide—KCNMA1—decidua—ovarian cancer	0.00916	0.0219	CbGeAlD
Diazoxide—GLUL—gonad—ovarian cancer	0.00869	0.0208	CbGeAlD
Diazoxide—GLUL—uterus—ovarian cancer	0.00864	0.0207	CbGeAlD
Diazoxide—ABCC8—endometrium—ovarian cancer	0.0081	0.0194	CbGeAlD
Diazoxide—KCNMA1—gonad—ovarian cancer	0.00807	0.0193	CbGeAlD
Diazoxide—KCNMA1—uterus—ovarian cancer	0.00802	0.0192	CbGeAlD
Diazoxide—ATP1A1—myometrium—ovarian cancer	0.00794	0.019	CbGeAlD
Diazoxide—GLUL—female reproductive system—ovarian cancer	0.00776	0.0186	CbGeAlD
Diazoxide—ATP1A1—embryo—ovarian cancer	0.00764	0.0183	CbGeAlD
Diazoxide—GLUL—bone marrow—ovarian cancer	0.00733	0.0176	CbGeAlD
Diazoxide—KCNJ11—female reproductive system—ovarian cancer	0.00729	0.0175	CbGeAlD
Diazoxide—KCNMA1—female reproductive system—ovarian cancer	0.00721	0.0173	CbGeAlD
Diazoxide—GLUL—female gonad—ovarian cancer	0.00707	0.0169	CbGeAlD
Diazoxide—GLUL—vagina—ovarian cancer	0.00702	0.0168	CbGeAlD
Diazoxide—KCNJ11—female gonad—ovarian cancer	0.00663	0.0159	CbGeAlD
Diazoxide—GLUL—testis—ovarian cancer	0.00627	0.015	CbGeAlD
Diazoxide—ATP1A1—epithelium—ovarian cancer	0.00623	0.0149	CbGeAlD
Diazoxide—ATP1A1—uterine cervix—ovarian cancer	0.00618	0.0148	CbGeAlD
Diazoxide—ATP1A1—decidua—ovarian cancer	0.00589	0.0141	CbGeAlD
Diazoxide—CA2—embryo—ovarian cancer	0.00585	0.014	CbGeAlD
Diazoxide—KCNMA1—testis—ovarian cancer	0.00581	0.0139	CbGeAlD
Diazoxide—ATP1A1—endometrium—ovarian cancer	0.00559	0.0134	CbGeAlD
Diazoxide—CA1—female reproductive system—ovarian cancer	0.00547	0.0131	CbGeAlD
Diazoxide—ABCC8—testis—ovarian cancer	0.00542	0.013	CbGeAlD
Diazoxide—ATP1A1—gonad—ovarian cancer	0.00518	0.0124	CbGeAlD
Diazoxide—CA1—bone marrow—ovarian cancer	0.00517	0.0124	CbGeAlD
Diazoxide—ATP1A1—uterus—ovarian cancer	0.00515	0.0123	CbGeAlD
Diazoxide—CA2—epithelium—ovarian cancer	0.00478	0.0114	CbGeAlD
Diazoxide—ATP1A1—female reproductive system—ovarian cancer	0.00463	0.0111	CbGeAlD
Diazoxide—GLUL—lymph node—ovarian cancer	0.00454	0.0109	CbGeAlD
Diazoxide—CA2—decidua—ovarian cancer	0.00451	0.0108	CbGeAlD
Diazoxide—ATP1A1—bone marrow—ovarian cancer	0.00437	0.0105	CbGeAlD
Diazoxide—KCNJ11—lymph node—ovarian cancer	0.00426	0.0102	CbGeAlD
Diazoxide—KCNMA1—lymph node—ovarian cancer	0.00421	0.0101	CbGeAlD
Diazoxide—ATP1A1—female gonad—ovarian cancer	0.00421	0.0101	CbGeAlD
Diazoxide—ATP1A1—vagina—ovarian cancer	0.00419	0.01	CbGeAlD
Diazoxide—ATP1A1—testis—ovarian cancer	0.00374	0.00895	CbGeAlD
Diazoxide—CA2—female reproductive system—ovarian cancer	0.00355	0.0085	CbGeAlD
Diazoxide—CA2—bone marrow—ovarian cancer	0.00335	0.00802	CbGeAlD
Diazoxide—CA2—female gonad—ovarian cancer	0.00323	0.00773	CbGeAlD
Diazoxide—CA2—vagina—ovarian cancer	0.00321	0.00768	CbGeAlD
Diazoxide—CA1—lymph node—ovarian cancer	0.0032	0.00767	CbGeAlD
Diazoxide—ATP1A1—Ion transport by P-type ATPases—ATP7B—ovarian cancer	0.00288	0.0658	CbGpPWpGaD
Diazoxide—CA2—testis—ovarian cancer	0.00286	0.00686	CbGeAlD
Diazoxide—ATP1A1—lymph node—ovarian cancer	0.00271	0.00649	CbGeAlD
Diazoxide—ATP1A1—Preimplantation Embryo—AQP3—ovarian cancer	0.00237	0.054	CbGpPWpGaD
Diazoxide—CA2—lymph node—ovarian cancer	0.00208	0.00497	CbGeAlD
Diazoxide—Discomfort—Topotecan—ovarian cancer	0.00205	0.0038	CcSEcCtD
Diazoxide—Chest pain—Melphalan—ovarian cancer	0.00203	0.00376	CcSEcCtD
Diazoxide—Lacrimation increased—Epirubicin—ovarian cancer	0.00199	0.00369	CcSEcCtD
Diazoxide—Pancreatitis—Paclitaxel—ovarian cancer	0.00197	0.00365	CcSEcCtD
Diazoxide—Oedema—Melphalan—ovarian cancer	0.00194	0.00361	CcSEcCtD
Diazoxide—Thrombocytopenia—Topotecan—ovarian cancer	0.00194	0.00361	CcSEcCtD
Diazoxide—Decreased appetite—Chlorambucil—ovarian cancer	0.00194	0.0036	CcSEcCtD
Diazoxide—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00193	0.00358	CcSEcCtD
Diazoxide—Hyperhidrosis—Topotecan—ovarian cancer	0.00192	0.00356	CcSEcCtD
Diazoxide—Pain—Chlorambucil—ovarian cancer	0.00191	0.00354	CcSEcCtD
Diazoxide—Thrombocytopenia—Melphalan—ovarian cancer	0.0019	0.00353	CcSEcCtD
Diazoxide—Tachycardia—Melphalan—ovarian cancer	0.0019	0.00352	CcSEcCtD
Diazoxide—Anorexia—Topotecan—ovarian cancer	0.00189	0.00351	CcSEcCtD
Diazoxide—Malaise—Vinorelbine—ovarian cancer	0.00188	0.00348	CcSEcCtD
Diazoxide—Leukopenia—Vinorelbine—ovarian cancer	0.00186	0.00346	CcSEcCtD
Diazoxide—Anorexia—Melphalan—ovarian cancer	0.00185	0.00344	CcSEcCtD
Diazoxide—Palpitations—Vinorelbine—ovarian cancer	0.00184	0.00341	CcSEcCtD
Diazoxide—Lacrimation increased—Doxorubicin—ovarian cancer	0.00184	0.00341	CcSEcCtD
Diazoxide—Feeling abnormal—Chlorambucil—ovarian cancer	0.00184	0.00341	CcSEcCtD
Diazoxide—Weight increased—Paclitaxel—ovarian cancer	0.00183	0.00339	CcSEcCtD
Diazoxide—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00182	0.00338	CcSEcCtD
Diazoxide—Hypotension—Melphalan—ovarian cancer	0.00182	0.00337	CcSEcCtD
Diazoxide—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00181	0.00336	CcSEcCtD
Diazoxide—Hypertension—Vinorelbine—ovarian cancer	0.0018	0.00333	CcSEcCtD
Diazoxide—Paraesthesia—Topotecan—ovarian cancer	0.00178	0.00331	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00177	0.00329	CcSEcCtD
Diazoxide—Chest pain—Vinorelbine—ovarian cancer	0.00177	0.00329	CcSEcCtD
Diazoxide—Abdominal pain—Chlorambucil—ovarian cancer	0.00176	0.00327	CcSEcCtD
Diazoxide—Body temperature increased—Chlorambucil—ovarian cancer	0.00176	0.00327	CcSEcCtD
Diazoxide—Discomfort—Vinorelbine—ovarian cancer	0.00175	0.00325	CcSEcCtD
Diazoxide—Paraesthesia—Melphalan—ovarian cancer	0.00174	0.00324	CcSEcCtD
Diazoxide—Fluid retention—Epirubicin—ovarian cancer	0.00174	0.00322	CcSEcCtD
Diazoxide—Decreased appetite—Topotecan—ovarian cancer	0.00172	0.0032	CcSEcCtD
Diazoxide—Haematuria—Paclitaxel—ovarian cancer	0.00171	0.00317	CcSEcCtD
Diazoxide—Pain—Topotecan—ovarian cancer	0.0017	0.00315	CcSEcCtD
Diazoxide—Decreased appetite—Melphalan—ovarian cancer	0.00169	0.00314	CcSEcCtD
Diazoxide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00166	0.00309	CcSEcCtD
Diazoxide—Pain—Melphalan—ovarian cancer	0.00166	0.00308	CcSEcCtD
Diazoxide—Tachycardia—Vinorelbine—ovarian cancer	0.00166	0.00308	CcSEcCtD
Diazoxide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00164	0.00305	CcSEcCtD
Diazoxide—Feeling abnormal—Topotecan—ovarian cancer	0.00164	0.00304	CcSEcCtD
Diazoxide—Gastrointestinal pain—Topotecan—ovarian cancer	0.00162	0.00301	CcSEcCtD
Diazoxide—Anorexia—Vinorelbine—ovarian cancer	0.00162	0.003	CcSEcCtD
Diazoxide—Haemoglobin—Paclitaxel—ovarian cancer	0.00162	0.003	CcSEcCtD
Diazoxide—Fluid retention—Doxorubicin—ovarian cancer	0.00161	0.00298	CcSEcCtD
Diazoxide—Haemorrhage—Paclitaxel—ovarian cancer	0.00161	0.00298	CcSEcCtD
Diazoxide—Asthenia—Chlorambucil—ovarian cancer	0.0016	0.00297	CcSEcCtD
Diazoxide—Hypotension—Vinorelbine—ovarian cancer	0.00159	0.00294	CcSEcCtD
Diazoxide—Pruritus—Chlorambucil—ovarian cancer	0.00158	0.00293	CcSEcCtD
Diazoxide—Abdominal pain—Topotecan—ovarian cancer	0.00157	0.00291	CcSEcCtD
Diazoxide—Body temperature increased—Topotecan—ovarian cancer	0.00157	0.00291	CcSEcCtD
Diazoxide—Lymphadenopathy—Epirubicin—ovarian cancer	0.00156	0.00289	CcSEcCtD
Diazoxide—Weight increased—Docetaxel—ovarian cancer	0.00155	0.00288	CcSEcCtD
Diazoxide—Diarrhoea—Chlorambucil—ovarian cancer	0.00153	0.00283	CcSEcCtD
Diazoxide—Paraesthesia—Vinorelbine—ovarian cancer	0.00152	0.00283	CcSEcCtD
Diazoxide—Flushing—Paclitaxel—ovarian cancer	0.00149	0.00277	CcSEcCtD
Diazoxide—Vascular purpura—Epirubicin—ovarian cancer	0.00148	0.00276	CcSEcCtD
Diazoxide—Decreased appetite—Vinorelbine—ovarian cancer	0.00148	0.00274	CcSEcCtD
Diazoxide—Hypersensitivity—Topotecan—ovarian cancer	0.00146	0.00271	CcSEcCtD
Diazoxide—Pain—Vinorelbine—ovarian cancer	0.00145	0.00269	CcSEcCtD
Diazoxide—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00144	0.00267	CcSEcCtD
Diazoxide—Hypersensitivity—Melphalan—ovarian cancer	0.00143	0.00266	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—SMARCA4—ovarian cancer	0.00142	0.0325	CbGpPWpGaD
Diazoxide—Asthenia—Topotecan—ovarian cancer	0.00142	0.00264	CcSEcCtD
Diazoxide—Vomiting—Chlorambucil—ovarian cancer	0.00142	0.00263	CcSEcCtD
Diazoxide—Pruritus—Topotecan—ovarian cancer	0.0014	0.00261	CcSEcCtD
Diazoxide—Feeling abnormal—Vinorelbine—ovarian cancer	0.0014	0.0026	CcSEcCtD
Diazoxide—Asthenia—Melphalan—ovarian cancer	0.00139	0.00259	CcSEcCtD
Diazoxide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00139	0.00258	CcSEcCtD
Diazoxide—Purpura—Epirubicin—ovarian cancer	0.00138	0.00256	CcSEcCtD
Diazoxide—Pruritus—Melphalan—ovarian cancer	0.00137	0.00255	CcSEcCtD
Diazoxide—Vascular purpura—Doxorubicin—ovarian cancer	0.00137	0.00255	CcSEcCtD
Diazoxide—Haemoglobin—Docetaxel—ovarian cancer	0.00137	0.00254	CcSEcCtD
Diazoxide—Haemorrhage—Docetaxel—ovarian cancer	0.00136	0.00253	CcSEcCtD
Diazoxide—Diarrhoea—Topotecan—ovarian cancer	0.00136	0.00252	CcSEcCtD
Diazoxide—Abdominal pain—Vinorelbine—ovarian cancer	0.00134	0.00249	CcSEcCtD
Diazoxide—Body temperature increased—Vinorelbine—ovarian cancer	0.00134	0.00249	CcSEcCtD
Diazoxide—Diarrhoea—Melphalan—ovarian cancer	0.00133	0.00247	CcSEcCtD
Diazoxide—Diplopia—Epirubicin—ovarian cancer	0.00133	0.00247	CcSEcCtD
Diazoxide—Nausea—Chlorambucil—ovarian cancer	0.00132	0.00246	CcSEcCtD
Diazoxide—Vision blurred—Paclitaxel—ovarian cancer	0.00132	0.00245	CcSEcCtD
Diazoxide—Dizziness—Topotecan—ovarian cancer	0.00131	0.00244	CcSEcCtD
Diazoxide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.0013	0.00241	CcSEcCtD
Diazoxide—GLUL—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00128	0.0293	CbGpPWpGaD
Diazoxide—Purpura—Doxorubicin—ovarian cancer	0.00127	0.00237	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—IKBKG—ovarian cancer	0.00127	0.0289	CbGpPWpGaD
Diazoxide—Flushing—Docetaxel—ovarian cancer	0.00126	0.00235	CcSEcCtD
Diazoxide—Vomiting—Topotecan—ovarian cancer	0.00126	0.00234	CcSEcCtD
Diazoxide—Malaise—Paclitaxel—ovarian cancer	0.00126	0.00234	CcSEcCtD
Diazoxide—Leukopenia—Paclitaxel—ovarian cancer	0.00125	0.00232	CcSEcCtD
Diazoxide—Rash—Topotecan—ovarian cancer	0.00125	0.00232	CcSEcCtD
Diazoxide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00125	0.00232	CcSEcCtD
Diazoxide—Dermatitis—Topotecan—ovarian cancer	0.00125	0.00232	CcSEcCtD
Diazoxide—Headache—Topotecan—ovarian cancer	0.00124	0.00231	CcSEcCtD
Diazoxide—Palpitations—Paclitaxel—ovarian cancer	0.00124	0.0023	CcSEcCtD
Diazoxide—Vomiting—Melphalan—ovarian cancer	0.00124	0.00229	CcSEcCtD
Diazoxide—Diplopia—Doxorubicin—ovarian cancer	0.00123	0.00228	CcSEcCtD
Diazoxide—Rash—Melphalan—ovarian cancer	0.00123	0.00227	CcSEcCtD
Diazoxide—Dermatitis—Melphalan—ovarian cancer	0.00122	0.00227	CcSEcCtD
Diazoxide—Asthenia—Vinorelbine—ovarian cancer	0.00122	0.00226	CcSEcCtD
Diazoxide—Hypokalaemia—Epirubicin—ovarian cancer	0.00121	0.00224	CcSEcCtD
Diazoxide—Hypertension—Paclitaxel—ovarian cancer	0.00121	0.00224	CcSEcCtD
Diazoxide—Pruritus—Vinorelbine—ovarian cancer	0.0012	0.00223	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.0012	0.00222	CcSEcCtD
Diazoxide—Chest pain—Paclitaxel—ovarian cancer	0.00119	0.00221	CcSEcCtD
Diazoxide—Anxiety—Paclitaxel—ovarian cancer	0.00119	0.0022	CcSEcCtD
Diazoxide—Nausea—Topotecan—ovarian cancer	0.00118	0.00219	CcSEcCtD
Diazoxide—Discomfort—Paclitaxel—ovarian cancer	0.00118	0.00218	CcSEcCtD
Diazoxide—Diarrhoea—Vinorelbine—ovarian cancer	0.00116	0.00216	CcSEcCtD
Diazoxide—Nausea—Melphalan—ovarian cancer	0.00115	0.00214	CcSEcCtD
Diazoxide—Oedema—Paclitaxel—ovarian cancer	0.00114	0.00212	CcSEcCtD
Diazoxide—Eosinophilia—Epirubicin—ovarian cancer	0.00114	0.00211	CcSEcCtD
Diazoxide—Pancreatitis—Epirubicin—ovarian cancer	0.00113	0.00209	CcSEcCtD
Diazoxide—Dizziness—Vinorelbine—ovarian cancer	0.00112	0.00208	CcSEcCtD
Diazoxide—Hypokalaemia—Doxorubicin—ovarian cancer	0.00112	0.00208	CcSEcCtD
Diazoxide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00112	0.00208	CcSEcCtD
Diazoxide—Tachycardia—Paclitaxel—ovarian cancer	0.00111	0.00207	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00111	0.00205	CcSEcCtD
Diazoxide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0011	0.00205	CcSEcCtD
Diazoxide—Anorexia—Paclitaxel—ovarian cancer	0.00109	0.00202	CcSEcCtD
Diazoxide—Vomiting—Vinorelbine—ovarian cancer	0.00108	0.002	CcSEcCtD
Diazoxide—Rash—Vinorelbine—ovarian cancer	0.00107	0.00199	CcSEcCtD
Diazoxide—Dermatitis—Vinorelbine—ovarian cancer	0.00107	0.00199	CcSEcCtD
Diazoxide—Hypotension—Paclitaxel—ovarian cancer	0.00107	0.00198	CcSEcCtD
Diazoxide—Headache—Vinorelbine—ovarian cancer	0.00106	0.00197	CcSEcCtD
Diazoxide—Leukopenia—Docetaxel—ovarian cancer	0.00106	0.00197	CcSEcCtD
Diazoxide—Eosinophilia—Doxorubicin—ovarian cancer	0.00105	0.00195	CcSEcCtD
Diazoxide—Palpitations—Docetaxel—ovarian cancer	0.00105	0.00195	CcSEcCtD
Diazoxide—Weight increased—Epirubicin—ovarian cancer	0.00104	0.00194	CcSEcCtD
Diazoxide—Pancreatitis—Doxorubicin—ovarian cancer	0.00104	0.00193	CcSEcCtD
Diazoxide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00104	0.00192	CcSEcCtD
Diazoxide—Insomnia—Paclitaxel—ovarian cancer	0.00103	0.00192	CcSEcCtD
Diazoxide—Paraesthesia—Paclitaxel—ovarian cancer	0.00103	0.0019	CcSEcCtD
Diazoxide—Hypertension—Docetaxel—ovarian cancer	0.00102	0.0019	CcSEcCtD
Diazoxide—Chest pain—Docetaxel—ovarian cancer	0.00101	0.00187	CcSEcCtD
Diazoxide—Nausea—Vinorelbine—ovarian cancer	0.00101	0.00187	CcSEcCtD
Diazoxide—ATP1A1—Ion channel transport—ATP7B—ovarian cancer	0.000998	0.0228	CbGpPWpGaD
Diazoxide—Decreased appetite—Paclitaxel—ovarian cancer	0.000993	0.00184	CcSEcCtD
Diazoxide—GLUL—Neuronal System—NSF—ovarian cancer	0.000983	0.0224	CbGpPWpGaD
Diazoxide—Sweating—Epirubicin—ovarian cancer	0.000981	0.00182	CcSEcCtD
Diazoxide—Pain—Paclitaxel—ovarian cancer	0.000976	0.00181	CcSEcCtD
Diazoxide—Haematuria—Epirubicin—ovarian cancer	0.000976	0.00181	CcSEcCtD
Diazoxide—Oedema—Docetaxel—ovarian cancer	0.000968	0.0018	CcSEcCtD
Diazoxide—Weight increased—Doxorubicin—ovarian cancer	0.000967	0.00179	CcSEcCtD
Diazoxide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000958	0.00178	CcSEcCtD
Diazoxide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000948	0.00176	CcSEcCtD
Diazoxide—Tachycardia—Docetaxel—ovarian cancer	0.000944	0.00175	CcSEcCtD
Diazoxide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000941	0.00175	CcSEcCtD
Diazoxide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000934	0.00173	CcSEcCtD
Diazoxide—Haemoglobin—Epirubicin—ovarian cancer	0.000923	0.00171	CcSEcCtD
Diazoxide—Anorexia—Docetaxel—ovarian cancer	0.000922	0.00171	CcSEcCtD
Diazoxide—Haemorrhage—Epirubicin—ovarian cancer	0.000919	0.00171	CcSEcCtD
Diazoxide—Sweating—Doxorubicin—ovarian cancer	0.000908	0.00169	CcSEcCtD
Diazoxide—Hypotension—Docetaxel—ovarian cancer	0.000904	0.00168	CcSEcCtD
Diazoxide—Haematuria—Doxorubicin—ovarian cancer	0.000903	0.00168	CcSEcCtD
Diazoxide—Abdominal pain—Paclitaxel—ovarian cancer	0.000903	0.00168	CcSEcCtD
Diazoxide—Body temperature increased—Paclitaxel—ovarian cancer	0.000903	0.00168	CcSEcCtD
Diazoxide—ABCC8—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000901	0.0206	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TOP1—ovarian cancer	0.000893	0.0204	CbGpPWpGaD
Diazoxide—Insomnia—Docetaxel—ovarian cancer	0.000875	0.00162	CcSEcCtD
Diazoxide—Paraesthesia—Docetaxel—ovarian cancer	0.000869	0.00161	CcSEcCtD
Diazoxide—Haemoglobin—Doxorubicin—ovarian cancer	0.000854	0.00159	CcSEcCtD
Diazoxide—Flushing—Epirubicin—ovarian cancer	0.000853	0.00158	CcSEcCtD
Diazoxide—Haemorrhage—Doxorubicin—ovarian cancer	0.00085	0.00158	CcSEcCtD
Diazoxide—Decreased appetite—Docetaxel—ovarian cancer	0.000841	0.00156	CcSEcCtD
Diazoxide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000841	0.00156	CcSEcCtD
Diazoxide—Pain—Docetaxel—ovarian cancer	0.000828	0.00154	CcSEcCtD
Diazoxide—Asthenia—Paclitaxel—ovarian cancer	0.000819	0.00152	CcSEcCtD
Diazoxide—Pruritus—Paclitaxel—ovarian cancer	0.000808	0.0015	CcSEcCtD
Diazoxide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—ovarian cancer	0.000806	0.0184	CbGpPWpGaD
Diazoxide—Feeling abnormal—Docetaxel—ovarian cancer	0.000797	0.00148	CcSEcCtD
Diazoxide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000791	0.00147	CcSEcCtD
Diazoxide—Flushing—Doxorubicin—ovarian cancer	0.000789	0.00146	CcSEcCtD
Diazoxide—Diarrhoea—Paclitaxel—ovarian cancer	0.000781	0.00145	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—PPP1CC—ovarian cancer	0.00078	0.0178	CbGpPWpGaD
Diazoxide—Body temperature increased—Docetaxel—ovarian cancer	0.000765	0.00142	CcSEcCtD
Diazoxide—Abdominal pain—Docetaxel—ovarian cancer	0.000765	0.00142	CcSEcCtD
Diazoxide—Dizziness—Paclitaxel—ovarian cancer	0.000755	0.0014	CcSEcCtD
Diazoxide—Vision blurred—Epirubicin—ovarian cancer	0.000754	0.0014	CcSEcCtD
Diazoxide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000742	0.00138	CcSEcCtD
Diazoxide—KCNMA1—Platelet homeostasis—PPP2R1A—ovarian cancer	0.000735	0.0168	CbGpPWpGaD
Diazoxide—Vomiting—Paclitaxel—ovarian cancer	0.000726	0.00135	CcSEcCtD
Diazoxide—Malaise—Epirubicin—ovarian cancer	0.000721	0.00134	CcSEcCtD
Diazoxide—Rash—Paclitaxel—ovarian cancer	0.00072	0.00134	CcSEcCtD
Diazoxide—Dermatitis—Paclitaxel—ovarian cancer	0.000719	0.00134	CcSEcCtD
Diazoxide—Leukopenia—Epirubicin—ovarian cancer	0.000716	0.00133	CcSEcCtD
Diazoxide—KCNJ11—Type II diabetes mellitus—MTOR—ovarian cancer	0.000716	0.0163	CbGpPWpGaD
Diazoxide—Headache—Paclitaxel—ovarian cancer	0.000715	0.00133	CcSEcCtD
Diazoxide—Hypersensitivity—Docetaxel—ovarian cancer	0.000713	0.00132	CcSEcCtD
Diazoxide—Palpitations—Epirubicin—ovarian cancer	0.000707	0.00131	CcSEcCtD
Diazoxide—KCNMA1—Neuronal System—NSF—ovarian cancer	0.000706	0.0161	CbGpPWpGaD
Diazoxide—Vision blurred—Doxorubicin—ovarian cancer	0.000697	0.00129	CcSEcCtD
Diazoxide—Asthenia—Docetaxel—ovarian cancer	0.000694	0.00129	CcSEcCtD
Diazoxide—Hypertension—Epirubicin—ovarian cancer	0.000691	0.00128	CcSEcCtD
Diazoxide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000687	0.00127	CcSEcCtD
Diazoxide—Pruritus—Docetaxel—ovarian cancer	0.000685	0.00127	CcSEcCtD
Diazoxide—Chest pain—Epirubicin—ovarian cancer	0.000681	0.00126	CcSEcCtD
Diazoxide—Anxiety—Epirubicin—ovarian cancer	0.000679	0.00126	CcSEcCtD
Diazoxide—Nausea—Paclitaxel—ovarian cancer	0.000678	0.00126	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—HNF1B—ovarian cancer	0.000677	0.0154	CbGpPWpGaD
Diazoxide—Discomfort—Epirubicin—ovarian cancer	0.000673	0.00125	CcSEcCtD
Diazoxide—Malaise—Doxorubicin—ovarian cancer	0.000667	0.00124	CcSEcCtD
Diazoxide—Leukopenia—Doxorubicin—ovarian cancer	0.000662	0.00123	CcSEcCtD
Diazoxide—Diarrhoea—Docetaxel—ovarian cancer	0.000662	0.00123	CcSEcCtD
Diazoxide—Palpitations—Doxorubicin—ovarian cancer	0.000654	0.00121	CcSEcCtD
Diazoxide—Oedema—Epirubicin—ovarian cancer	0.000653	0.00121	CcSEcCtD
Diazoxide—Dizziness—Docetaxel—ovarian cancer	0.00064	0.00119	CcSEcCtD
Diazoxide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000639	0.00119	CcSEcCtD
Diazoxide—Hypertension—Doxorubicin—ovarian cancer	0.000639	0.00119	CcSEcCtD
Diazoxide—Tachycardia—Epirubicin—ovarian cancer	0.000637	0.00118	CcSEcCtD
Diazoxide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000631	0.00117	CcSEcCtD
Diazoxide—Chest pain—Doxorubicin—ovarian cancer	0.00063	0.00117	CcSEcCtD
Diazoxide—Anxiety—Doxorubicin—ovarian cancer	0.000628	0.00117	CcSEcCtD
Diazoxide—Discomfort—Doxorubicin—ovarian cancer	0.000622	0.00116	CcSEcCtD
Diazoxide—Anorexia—Epirubicin—ovarian cancer	0.000622	0.00116	CcSEcCtD
Diazoxide—ABCC8—Regulation of insulin secretion—SLC2A1—ovarian cancer	0.000621	0.0142	CbGpPWpGaD
Diazoxide—GLUL—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.000616	0.0141	CbGpPWpGaD
Diazoxide—Vomiting—Docetaxel—ovarian cancer	0.000615	0.00114	CcSEcCtD
Diazoxide—Rash—Docetaxel—ovarian cancer	0.00061	0.00113	CcSEcCtD
Diazoxide—Hypotension—Epirubicin—ovarian cancer	0.00061	0.00113	CcSEcCtD
Diazoxide—Dermatitis—Docetaxel—ovarian cancer	0.00061	0.00113	CcSEcCtD
Diazoxide—Headache—Docetaxel—ovarian cancer	0.000606	0.00113	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—CDH1—ovarian cancer	0.000605	0.0138	CbGpPWpGaD
Diazoxide—Oedema—Doxorubicin—ovarian cancer	0.000604	0.00112	CcSEcCtD
Diazoxide—KCNJ11—Regulation of insulin secretion—SLC2A1—ovarian cancer	0.000602	0.0137	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000591	0.0011	CcSEcCtD
Diazoxide—Insomnia—Epirubicin—ovarian cancer	0.00059	0.0011	CcSEcCtD
Diazoxide—Tachycardia—Doxorubicin—ovarian cancer	0.000589	0.00109	CcSEcCtD
Diazoxide—Paraesthesia—Epirubicin—ovarian cancer	0.000586	0.00109	CcSEcCtD
Diazoxide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000584	0.00108	CcSEcCtD
Diazoxide—Anorexia—Doxorubicin—ovarian cancer	0.000576	0.00107	CcSEcCtD
Diazoxide—Nausea—Docetaxel—ovarian cancer	0.000575	0.00107	CcSEcCtD
Diazoxide—Decreased appetite—Epirubicin—ovarian cancer	0.000567	0.00105	CcSEcCtD
Diazoxide—Hypotension—Doxorubicin—ovarian cancer	0.000564	0.00105	CcSEcCtD
Diazoxide—Pain—Epirubicin—ovarian cancer	0.000558	0.00104	CcSEcCtD
Diazoxide—Insomnia—Doxorubicin—ovarian cancer	0.000546	0.00101	CcSEcCtD
Diazoxide—Paraesthesia—Doxorubicin—ovarian cancer	0.000542	0.00101	CcSEcCtD
Diazoxide—Feeling abnormal—Epirubicin—ovarian cancer	0.000538	0.000999	CcSEcCtD
Diazoxide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000534	0.000991	CcSEcCtD
Diazoxide—Decreased appetite—Doxorubicin—ovarian cancer	0.000525	0.000975	CcSEcCtD
Diazoxide—Pain—Doxorubicin—ovarian cancer	0.000516	0.000959	CcSEcCtD
Diazoxide—Abdominal pain—Epirubicin—ovarian cancer	0.000516	0.000958	CcSEcCtD
Diazoxide—Body temperature increased—Epirubicin—ovarian cancer	0.000516	0.000958	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—FASN—ovarian cancer	0.000514	0.0117	CbGpPWpGaD
Diazoxide—KCNJ11—Type II diabetes mellitus—MAPK1—ovarian cancer	0.000503	0.0115	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—NSF—ovarian cancer	0.000502	0.0115	CbGpPWpGaD
Diazoxide—KCNJ11—Integration of energy metabolism—FASN—ovarian cancer	0.000499	0.0114	CbGpPWpGaD
Diazoxide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000498	0.000924	CcSEcCtD
Diazoxide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000494	0.000917	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—SLC2A1—ovarian cancer	0.000488	0.0111	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—NSF—ovarian cancer	0.000487	0.0111	CbGpPWpGaD
Diazoxide—Hypersensitivity—Epirubicin—ovarian cancer	0.000481	0.000893	CcSEcCtD
Diazoxide—Body temperature increased—Doxorubicin—ovarian cancer	0.000477	0.000886	CcSEcCtD
Diazoxide—Abdominal pain—Doxorubicin—ovarian cancer	0.000477	0.000886	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—SLC2A1—ovarian cancer	0.000474	0.0108	CbGpPWpGaD
Diazoxide—Asthenia—Epirubicin—ovarian cancer	0.000468	0.000869	CcSEcCtD
Diazoxide—Pruritus—Epirubicin—ovarian cancer	0.000462	0.000857	CcSEcCtD
Diazoxide—Diarrhoea—Epirubicin—ovarian cancer	0.000447	0.000829	CcSEcCtD
Diazoxide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000445	0.000826	CcSEcCtD
Diazoxide—Asthenia—Doxorubicin—ovarian cancer	0.000433	0.000804	CcSEcCtD
Diazoxide—Dizziness—Epirubicin—ovarian cancer	0.000432	0.000801	CcSEcCtD
Diazoxide—Pruritus—Doxorubicin—ovarian cancer	0.000427	0.000793	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—RAD51C—ovarian cancer	0.000427	0.00973	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CASP3—ovarian cancer	0.000423	0.00965	CbGpPWpGaD
Diazoxide—ABCC8—Integration of energy metabolism—PPP2R1A—ovarian cancer	0.000415	0.00947	CbGpPWpGaD
Diazoxide—Vomiting—Epirubicin—ovarian cancer	0.000415	0.00077	CcSEcCtD
Diazoxide—Diarrhoea—Doxorubicin—ovarian cancer	0.000413	0.000767	CcSEcCtD
Diazoxide—Rash—Epirubicin—ovarian cancer	0.000412	0.000764	CcSEcCtD
Diazoxide—Dermatitis—Epirubicin—ovarian cancer	0.000411	0.000763	CcSEcCtD
Diazoxide—Headache—Epirubicin—ovarian cancer	0.000409	0.000759	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—PPP2R1A—ovarian cancer	0.000403	0.00919	CbGpPWpGaD
Diazoxide—Dizziness—Doxorubicin—ovarian cancer	0.000399	0.000741	CcSEcCtD
Diazoxide—Nausea—Epirubicin—ovarian cancer	0.000388	0.00072	CcSEcCtD
Diazoxide—Vomiting—Doxorubicin—ovarian cancer	0.000384	0.000713	CcSEcCtD
Diazoxide—Rash—Doxorubicin—ovarian cancer	0.000381	0.000707	CcSEcCtD
Diazoxide—Dermatitis—Doxorubicin—ovarian cancer	0.00038	0.000706	CcSEcCtD
Diazoxide—Headache—Doxorubicin—ovarian cancer	0.000378	0.000702	CcSEcCtD
Diazoxide—GLUL—Metabolism—NME2—ovarian cancer	0.000374	0.00852	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000362	0.00826	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000362	0.00826	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.00036	0.00822	CbGpPWpGaD
Diazoxide—Nausea—Doxorubicin—ovarian cancer	0.000359	0.000666	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—NRAS—ovarian cancer	0.000354	0.00809	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000348	0.00794	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000347	0.00792	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000347	0.00792	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—MAPK3—ovarian cancer	0.000339	0.00774	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—MAPK1—ovarian cancer	0.000323	0.00737	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TYMS—ovarian cancer	0.000314	0.00717	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—ovarian cancer	0.000305	0.00696	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.000279	0.00636	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000274	0.00626	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000274	0.00626	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—ovarian cancer	0.000266	0.00607	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—HRAS—ovarian cancer	0.000259	0.00592	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—IL6—ovarian cancer	0.000248	0.00566	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000244	0.00557	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYTB—ovarian cancer	0.000241	0.00549	CbGpPWpGaD
Diazoxide—CA2—Metabolism—NME2—ovarian cancer	0.000234	0.00534	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000234	0.00534	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—NRAS—ovarian cancer	0.000229	0.00523	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—AKT1—ovarian cancer	0.000229	0.00522	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SPARC—ovarian cancer	0.000228	0.0052	CbGpPWpGaD
Diazoxide—CA1—Metabolism—NME2—ovarian cancer	0.000225	0.00512	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—MYC—ovarian cancer	0.000213	0.00487	CbGpPWpGaD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000211	0.00482	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—BRIP1—ovarian cancer	0.00021	0.0048	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPP1CC—ovarian cancer	0.00021	0.0048	CbGpPWpGaD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000205	0.00467	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—ovarian cancer	0.000197	0.0045	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—NME2—ovarian cancer	0.000191	0.00436	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—NME2—ovarian cancer	0.000185	0.00422	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000185	0.00422	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000183	0.00418	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000183	0.00418	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000177	0.00403	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000177	0.00403	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000174	0.00396	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—HRAS—ovarian cancer	0.000168	0.00382	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SOD1—ovarian cancer	0.000166	0.00378	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PPP2R1A—ovarian cancer	0.000165	0.00376	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PTEN—ovarian cancer	0.000153	0.00348	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYTB—ovarian cancer	0.000151	0.00344	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYTB—ovarian cancer	0.000145	0.0033	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—YAP1—ovarian cancer	0.000141	0.00322	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00014	0.00319	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00014	0.00319	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000139	0.00318	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—MAPK1—ovarian cancer	0.000133	0.00303	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPP1CC—ovarian cancer	0.000132	0.00301	CbGpPWpGaD
Diazoxide—CA2—Metabolism—BRIP1—ovarian cancer	0.000132	0.00301	CbGpPWpGaD
Diazoxide—CA1—Metabolism—BRIP1—ovarian cancer	0.000126	0.00289	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPP1CC—ovarian cancer	0.000126	0.00289	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000123	0.00282	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYTB—ovarian cancer	0.000123	0.00281	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—CAV1—ovarian cancer	0.000121	0.00276	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYTB—ovarian cancer	0.000119	0.00272	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000119	0.00272	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—FASN—ovarian cancer	0.000115	0.00262	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC5A5—ovarian cancer	0.000113	0.00258	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CG—ovarian cancer	0.00011	0.00251	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—SLC2A1—ovarian cancer	0.000109	0.00249	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—BRIP1—ovarian cancer	0.000108	0.00245	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPP1CC—ovarian cancer	0.000108	0.00245	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—HRAS—ovarian cancer	0.000107	0.00244	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CYP1B1—ovarian cancer	0.000105	0.00239	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—BRIP1—ovarian cancer	0.000104	0.00238	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPP1CC—ovarian cancer	0.000104	0.00238	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—ovarian cancer	0.000104	0.00238	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CD—ovarian cancer	9.69e-05	0.00221	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—MAPK1—ovarian cancer	9.55e-05	0.00218	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—IL6—ovarian cancer	9.54e-05	0.00218	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.42e-05	0.00215	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPP2R1A—ovarian cancer	9.29e-05	0.00212	CbGpPWpGaD
Diazoxide—CA2—Metabolism—YAP1—ovarian cancer	8.85e-05	0.00202	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—ABCB1—ovarian cancer	8.63e-05	0.00197	CbGpPWpGaD
Diazoxide—CA1—Metabolism—YAP1—ovarian cancer	8.48e-05	0.00194	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TYMS—ovarian cancer	8.48e-05	0.00193	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CB—ovarian cancer	8.45e-05	0.00193	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—IL2—ovarian cancer	7.76e-05	0.00177	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—HRAS—ovarian cancer	7.67e-05	0.00175	CbGpPWpGaD
Diazoxide—CA2—Metabolism—FASN—ovarian cancer	7.21e-05	0.00165	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—YAP1—ovarian cancer	7.21e-05	0.00165	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC5A5—ovarian cancer	7.09e-05	0.00162	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—YAP1—ovarian cancer	6.99e-05	0.0016	CbGpPWpGaD
Diazoxide—CA1—Metabolism—FASN—ovarian cancer	6.91e-05	0.00158	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC2A1—ovarian cancer	6.85e-05	0.00156	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CAV1—ovarian cancer	6.83e-05	0.00156	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC5A5—ovarian cancer	6.8e-05	0.00155	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—MAPK1—ovarian cancer	6.79e-05	0.00155	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VEGFA—ovarian cancer	6.59e-05	0.0015	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—MAPK1—ovarian cancer	6.59e-05	0.0015	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CYP1B1—ovarian cancer	6.57e-05	0.0015	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC2A1—ovarian cancer	6.57e-05	0.0015	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NRAS—ovarian cancer	6.51e-05	0.00149	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CYP1B1—ovarian cancer	6.3e-05	0.00144	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—MAPK3—ovarian cancer	6.24e-05	0.00142	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CG—ovarian cancer	6.22e-05	0.00142	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—MAPK1—ovarian cancer	5.93e-05	0.00135	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—FASN—ovarian cancer	5.88e-05	0.00134	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPP2R1A—ovarian cancer	5.83e-05	0.00133	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC5A5—ovarian cancer	5.78e-05	0.00132	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—FASN—ovarian cancer	5.7e-05	0.0013	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC5A5—ovarian cancer	5.61e-05	0.00128	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—ovarian cancer	5.6e-05	0.00128	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPP2R1A—ovarian cancer	5.59e-05	0.00127	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC2A1—ovarian cancer	5.59e-05	0.00127	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CD—ovarian cancer	5.47e-05	0.00125	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—HRAS—ovarian cancer	5.46e-05	0.00124	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC2A1—ovarian cancer	5.42e-05	0.00124	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ABCB1—ovarian cancer	5.41e-05	0.00123	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CYP1B1—ovarian cancer	5.35e-05	0.00122	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMS—ovarian cancer	5.31e-05	0.00121	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—HRAS—ovarian cancer	5.29e-05	0.00121	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CYP1B1—ovarian cancer	5.19e-05	0.00118	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ABCB1—ovarian cancer	5.19e-05	0.00118	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CA—ovarian cancer	5.15e-05	0.00117	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMS—ovarian cancer	5.09e-05	0.00116	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—ovarian cancer	4.98e-05	0.00114	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CB—ovarian cancer	4.77e-05	0.00109	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HRAS—ovarian cancer	4.76e-05	0.00109	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPP2R1A—ovarian cancer	4.75e-05	0.00108	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPP2R1A—ovarian cancer	4.61e-05	0.00105	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ABCB1—ovarian cancer	4.41e-05	0.00101	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TYMS—ovarian cancer	4.33e-05	0.000988	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CAV1—ovarian cancer	4.28e-05	0.000977	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ABCB1—ovarian cancer	4.28e-05	0.000976	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—AKT1—ovarian cancer	4.21e-05	0.00096	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMS—ovarian cancer	4.2e-05	0.000958	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTEN—ovarian cancer	4.12e-05	0.00094	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CAV1—ovarian cancer	4.1e-05	0.000936	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CG—ovarian cancer	3.9e-05	0.00089	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CG—ovarian cancer	3.74e-05	0.000853	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CAV1—ovarian cancer	3.49e-05	0.000796	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CD—ovarian cancer	3.43e-05	0.000782	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CAV1—ovarian cancer	3.38e-05	0.000772	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CD—ovarian cancer	3.29e-05	0.00075	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CG—ovarian cancer	3.18e-05	0.000725	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CG—ovarian cancer	3.08e-05	0.000703	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CB—ovarian cancer	2.99e-05	0.000682	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CA—ovarian cancer	2.91e-05	0.000663	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CB—ovarian cancer	2.86e-05	0.000654	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CD—ovarian cancer	2.79e-05	0.000638	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CD—ovarian cancer	2.71e-05	0.000618	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTEN—ovarian cancer	2.58e-05	0.000589	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTEN—ovarian cancer	2.48e-05	0.000565	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CB—ovarian cancer	2.44e-05	0.000556	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AKT1—ovarian cancer	2.37e-05	0.000542	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CB—ovarian cancer	2.36e-05	0.000539	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTEN—ovarian cancer	2.1e-05	0.00048	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTEN—ovarian cancer	2.04e-05	0.000466	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CA—ovarian cancer	1.82e-05	0.000416	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CA—ovarian cancer	1.75e-05	0.000398	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKT1—ovarian cancer	1.49e-05	0.000339	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CA—ovarian cancer	1.48e-05	0.000339	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CA—ovarian cancer	1.44e-05	0.000328	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKT1—ovarian cancer	1.43e-05	0.000325	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKT1—ovarian cancer	1.21e-05	0.000277	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKT1—ovarian cancer	1.18e-05	0.000268	CbGpPWpGaD
